Shareholder alert: ademi llp investigates whether chembio diagnostics, inc. has obtained a fair price in its transaction with biosynex

Milwaukee , april 20, 2023 /prnewswire/ -- ademi llp is investigating chembio (nasdaq: cemi) for possible breaches of fiduciary duty and other violations of law in its transaction with biosynex.  click here to learn how to join the action https://www.ademilaw.com/case/chembio-diagnostics-inc or call guri ademi toll-free at 866-264-3995.
CEMI Ratings Summary
CEMI Quant Ranking